Kenneth Cunningham - 01 Aug 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role: Director
Signature: /s/ Andrew Fisher, Attorney-in-fact for Kenneth Cunningham
Issuer symbol: VRNA
Transactions as of: 01 Aug 2025
Net transactions value: -$142,057
Form type: 4
Filing time: 05 Aug 2025, 20:32:17 UTC
Previous filing: 29 Apr 2025
Next filing: 08 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cunningham Kenneth	Director	3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM	/s/ Andrew Fisher, Attorney-in-fact for Kenneth Cunningham	05 Aug 2025	0001836878

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VRNA	Ordinary Shares	Options Exercise	$0	+24,000	+36%	$0.000000	90,584	01 Aug 2025	Direct	F1
transaction	VRNA	Ordinary Shares	Sale	$142,057	-10,808	-12%	$13.14	79,776	01 Aug 2025	Direct	F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRNA	Restricted Stock Units	Options Exercise	$0	-24,000	-25%	$0.000000	72,000	01 Aug 2025	Ordinary Shares	24,000		Direct	F1, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2	The sale reported in the Form 4 represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of the restricted stock units ("RSUs").
F3	The price reported represents the sale price of the ADSs divided by eight (8).
F4	Consists of 79,776 Ordinary Shares represented by 9,972 ADSs.
F5	Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
F6	The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney.